Overview
HCM market data
Price History
HCM price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for HCM. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Goldman Sachs Maintains Neutral on HUTCHMED (China), Lowers Price Target to $14Benzinga · Jul 23, 2026, 4:15 PM
B of A Securities Maintains Buy on HUTCHMED (China), Lowers Price Target to $17Benzinga · Jul 7, 2026, 2:35 PM
HUTCHMED's Experimental Drug Shows Durable Responses In Advanced Bile Duct Cancer TrialBenzinga · Jun 25, 2026, 4:15 PM
Johnson & Johnson Hits Target With IMAAVY In Rare Blood DisorderBenzinga · Jun 11, 2026, 5:15 PM